Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Feasibility Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

First line treatment for advanced ovarian carcinoma hyperthermic intraperitoneal chemotherapy (HIPEC) after optimal debulking.

Addition of HIPEC to the standard first line treatment of ovarian carcinoma.

Inclusion Criteria:

• stage III or only pleural stage IV ovarian carcinoma first line treatment

Exclusion Criteria:

• incomplete surgery poor performance status bad general condition